Photo of Ryan Corcoran from researchers.mgh.harvard.edu
Jun 26, 2024, 12:40
EGFR co-inhibition in KRAS
Megan Barnet, Medical Oncologist at The Kinghorn Cancer Centre, shared on X:
“Great summary from Ryan Corcoran (Mass General Cancer Center) re targeting RAS. Similar single agent ORR G12Cinh PDAC compared with NSCLC, vs CRC which improves with addition anti-EGFR. Supports KRAS good target in PDAC …just need to progress in G12D.”
Source: Megan Barnet/X
Jul 1, 2024, 03:08